Hydrophobic signalling molecules such as steroid hormones, oxysterols and retinoids are both produced and metabolized by members of the cytochrome P-450 super-family [l] . Many meguterium. This conserved activity is mediated by cytochrome P-450s of the 2 and 4 families in mammals [4, 5] and by the bacterial fatty acid hydroxylase, CYP102, found in B. meguterium [6] . A crystal structure has yet to be determined for any mammalian P-450; however, the structure of the haem domain of CYP102 has been solved, and this currently serves as a prototype for the computer modelling of mammalian P-450 structure and function [7, 8] .
T h e regulation of fatty acid hydroxylases by chemical stimuli has also been conserved throughout evolution. Fatty acid hydroxylases are highly inducible in mammals [4] , plants [9] and Volume 
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B. megaterium [lo] by exposure to or treatment with a group of compounds known as peroxisome proliferators (Table 1) . These compounds are named for their ability to cause the size and number of hepatic peroxisomes to increase in rodents. Peroxisome proliferators are thought to mimic fatty acids and perturb lipid metabolism, and it appears that induction of fatty acid hydroxylases may represent an adaptive response to these lipid imbalances. CYP4A enzymes are induced during a wide range of pathophysiological states that are known to involve imbalances in lipid homeostasis such as diabetes [ 113, hypertension and starvation. Peroxisome proliferators have been shown to alleviate salt-induced hypertension in the rat, and altered expression of the CYP4A2 gene has been found to co-segregate with hypertension in spontaneously hypertensive rats [12, 13] . This has led to the suggestion that CYP4A activation may play a preventative role in the pathology of hypertension. The mechanism of this is unknown, and a product of CYP4A2 metabolism, 20-HETE, is itself a potent vasoconstrictor [14] .
In mammals and B. megaterium the induction of fatty acid hydroxylase activities by peroxisome proliferators has been shown to be at the Table I Compounds that induce fatty acid hydroxylases
Shown is a list of compounds that induce CYP4A activity in the rodent liver. These compounds are structurally diverse and the human population is exposed to these chemicals both as pharmaceutical agents and as environmental contaminants. . In the PPARa-null mice, normal constitutive levels of CYP4A expression are observed, but the treatment of these mice with peroxisome proliferators does not result in an increase in CYP4A activity or in the activity of other hepatic markers of peroxisome proliferation. PPARs are members of the steroid hormone receptor superfamily, and as such they are formed by a well-defined domain structure [2] ( Figure 1A ). The most highly conserved region of these proteins is a DNA-binding domain that contains two well-defined, zincfinger motifs. The C-terminus comprises a ligand-binding domain and a ligand-dependent transactivation domain (AF2) that is responsible for the ligand-dependent association with transcriptional mediator proteins such as NCOR, TIF, RIP140 and SRCl [21-231. In the study of the responsive elements in the CYP4A6 gene it was observed that sequences immediately upstream of the zinc-finger-binding sites were required for high-efficiency binding of PPARI RXR ( Figure 1B ) [24] . These sequences were similar to those observed for the monomeric nuclear receptors RevErbA and ROR. Chimaeric studies of the PPAR molecule revealed that a putative helical region adjacent to the zinc fingers (CTE; Figure 1A ) could confer monomeric binding to this region [25] . It appears that this
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activity is repressed by the N-terminal domain of PPAR and could only be utilized in N-terminal truncations and in heterodimers with RXR. We believe that these additional DNA-sequence interactions allow specific signalling in a group of related nuclear receptors (e.g. hepatocyte nuclear factor-4, chicken ovalbumin upstream promotertranscription factor and apolipoprotein regulatory protein-1) that bind to similar DNA motifs [ 19, 241 . PPARa significantly activates the CYP4A6 gene in gene-transfer experiments without the presence of added inducer. It has been hypothesized that this intrinsic activation may be due to the presence of an endogenous ligand in the tissue-culture system [26] . A point mutation in the putative ligand-binding domain was isolated that reduced the intrinsic activation but was maximally activated by peroxisome proliferators at concentrations about 5-fold higher than those required for the wild-type receptor [26] . These results suggest that this mutant PPAR has a reduced affinity for the activating ligands and is not activated by the low levels of endogenous Figure 2C ). The mutated residue lies in a region of the protein that corresponds to helix 3 of RXR [27] . The corresponding Glu-275 residue of RXR projects well into the proposed ligand-binding pocket. The specific interactions of this residue in RXR and the ligand are not known, because of the lack of a ligand bound or holo-RXR structure. The ligand-bound structure has been determined for both the retinoic acid receptor (RAR) [28] and the thyroid hormone receptor (TR) [29] . Examination of these structures has revealed that helix 3 contains many of the most important interactions with both ligands, including the co-ordination of the carboxylate group ( Figure 2C ). Glu-282 is not conserved in either the RARy or TRa proteins; however, the corresponding position, Ala-225, of TRa is an important contact residue for the binding of thyroid hormone. Lys-336 of RARy, which corresponds to the residue immediately adjacent to Glu-282 of PPARa, is also a contact residue in the binding of all trans retinoic acid. It is of interest to note that the PPAR subfamily is highly divergent over helix 3 when compared with other nuclear receptor subfamilies ( Figure  2C ). The areas of greatest divergence appear to correspond to the ligand-contact residues of RAR and TR, thus suggesting that this diversity may play a role in the generation of pharmaco-(EBS)lZBSl logical selectivity within this subfamily [30] . It is clear that the functional dissection of this region will be of great importance in the rational design of drugs against diabetes, obesity and athero- type PPAR ligand-binding domains will facilitate such endeavours.
As mentioned before, the response to peroxisome proliferators precedes the evolution of nuclear receptors. This response to lipid perturbation is found in bacilli and in plants, organisms that do not contain any members of the nuclear-receptor superfamily. The CYP102 gene of B. megaterium is regulated by a protein known as Bm3R1 [16, 31] . Bm3R1 is a helix-loop-helix DNA-binding protein that is related to the tetracycline repressor, TetR [32] . The binding of Bm3R1 to its regulatory sequence is disrupted by fatty acids, peroxisome proliferators and nonsteroidal anti-inflammatory drugs (NSAIDs) [ 10, 161 . This leads to the transcriptional activation of the CYP102 operon. Studies using fluorescent and radiolabelled fatty acids have shown that Bm3R1 interacts directly with the inducing agents and functions as a sensor of fatty acids (C. N. A. Palmer, E. h e n , V, Hughes and C. R.
Wolf, unpublished work). The most potent of inducing compounds are the polyunsaturated fatty acids, including linoleic and arachidonic acid ( Figure 3A) . These polyunsaturated fatty acids induce effectively at M, whereas saturated fatty acids, peroxisome proliferators and NSAIDs induce CYP102 at 10-4-10-3 M. The polyunsaturated fatty acids are highly toxic to B. megaterium ( Figure 3B ) and only induce CYP102 activity over a very narrow range of concentrations. This response is transient, which indicates that the fatty acids are metabolically inactivated. It has been known for a long time that long-chain fatty acids are substrates for the CYP102 enzyme [6] . In fact, the oxidation of arachidonic acid by CYP102 is the most efficient reaction known to be performed by a cytochrome P-450, with a turnover rate of 3000 mol of arachidonic acid/mol of CYP102 per min [33] . This is 100-1000-fold greater than the rate of metabolism by mammalian P-450s and may be attributed to the efficient coupling of NADPH hydrolysis by the fused reductase domain of 
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CYP102. The concept that hydroxylation of fatty acids by CYP102 leads to an attenuation of their inducing ability has been established by the demonstration that the CYP102 0-1 hydroxylation product of phytanic acid is greatly reduced in its ability to induce CYP102 [34] . CYP102 is Wolf, unpublished work). The cultures then recover and re-enter logarithmic growth. In cultures that have been treated with the peroxisome proliferator nafenopin, the bacteria are resistant to the linoleic acid toxicity ( Figure 3B ). The sensing and metabolism of the fatty acids at concentrations directly below the concentrations required for the inhibition of these pathways provides an illustration of the elegance and efficiency of the action of the proteins encoded by the CYP102 operon. In summary, fatty acid hydroxylases have been conserved throughout evolution and are an adaptive response to fatty acid overload. The direct sensing of fatty acids by DNA-bound transcription factors has also been utilized throughout evolution; however, the structures of the lipid-sensing proteins are completely different. In mammals, the fatty acid sensor is a transcription factor whose interaction with the Volume 25 transcriptional machinery is enhanced by fatty acid binding; in bacilli the response system involves derepression in which the DNA-bound repressor is displaced from t h e regulatory sequences. T h i s appears to be a n intriguing example of convergent evolution that fulfils a similar role in both bacilli a n d mammals.
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